METHOD OF SAFE ADMINISTRATION OF ANTI-TAU ANTIBODY
Methods are described for safely administering to a subject in need thereof an anti-tau antibody that bind to tau, in particular that bind to a phosphorylated epitope on tau. The methods comprise administering a pharmaceutical composition comprising the anti-tau antibody, in which the anti-tau antib...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
05.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods are described for safely administering to a subject in need thereof an anti-tau antibody that bind to tau, in particular that bind to a phosphorylated epitope on tau. The methods comprise administering a pharmaceutical composition comprising the anti-tau antibody, in which the anti-tau antibody is administered in an amount of about 500 mg to 5000 mg per dose.
L'invention concerne des méthodes pour administrer en toute sécurité à un sujet qui en a besoin un anticorps anti-tau qui se lie à tau, en particulier qui se lie à un épitope phosphorylé sur tau. Les méthodes comprennent l'administration d'une composition pharmaceutique comprenant l'anticorps anti-tau, dans laquelle l'anticorps anti-tau est administré en une quantité d'environ 500 mg à 5 000 mg par dose. |
---|---|
Bibliography: | Application Number: CA20213199808 |